VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Dogma Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Drugging the Undruggable

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Dogma Therapeutics 致力于开发口服 PCSK9 抑制剂，用于治疗高胆固醇和心血管疾病。最新信息：2020-09 Dogma Therapeutics与阿斯利康 就口服PCSK9抑制剂项目全球权益达成收购协议

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy